Product
Fuzuloparib
1 clinical trial
2 indications
Indication
Ovarian CancerIndication
Ovarian DiseasesClinical trial
A Single-arm, Exploratory Study of Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian CancerStatus: Recruiting, Estimated PCD: 2025-12-31